MedTrace Logo

The Effect of Exergame-Supported Training on Reaction Time and Agility

NCT07765277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-08-14

No results posted yet for this study

Summary

This study looks at whether a type of exercise video game, called an exergame, can help adolescent boys with autism spectrum disorder (ASD) who play table tennis react faster and move more quickly (agility) during play. Twenty-four adolescent male table tennis players with mild ASD are taking part. Half of them add 20 minutes of exergame training, using a light-based reaction device, to their usual table tennis practice twice a week for 8 weeks. The other half continue their usual table tennis practice only, without the exergame. Reaction time is measured using a light-based reaction device, and agility is measured using a standard running drill (the T-test), before and after the 8-week period. This study aims to find out whether exergame training added to regular practice can help young table tennis players with ASD react and move faster during matches.

Conditions

Interventions

BEHAVIORAL

Exergame Training

Sensor-based exergame training using the BlazePod system (BlazePod Ltd., Tel Aviv, Israel), a light-reaction device with pods that illuminate according to programmable parameters (colour, duration, randomisation). Participants extinguished lit pods as quickly as possible using their hand (weeks 1 of each difficulty level) or a table tennis bat (week 2 of each difficulty level). Pod spacing and set duration (20-50 seconds) increased progressively across 4 difficulty levels over 8 weeks. Sessions were delivered one-to-one, supervised by the participant's own club coach following a standardised training manual and briefing.

Sponsors & Collaborators

  • Princess Nourah Bint Abdulrahman University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-25
Primary Completion
2026-07-15
Completion
2026-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07765277 on ClinicalTrials.gov